#Enflonsia #RSVprevention #Clesrovimab #monoclonalantibody #MHRA #MSD #respiratorysyncytialvirus #RSV #RSVseason #RSVnationalimmunisationprogramme #Paediatrics #neonatology #monoclonalantibodyprophylaxis #RSVdisease #CLEVERclinicaltrial #NEJM
zurl.co/toqIz
zurl.co/toqIz
UK medicines regulator grants marketing authorisation to Enflonsia for RSV prevention - PharmaTimes
Clesrovimab is first monoclonal antibody offering a single fixed dose for infants
pharmatimes.com
April 28, 2026 at 8:22 AM